OSE Immunotherapeutics to Present at Chardan Healthcare Conference

OSE Immunotherapeutics SA, a clinical-stage biotech company, is set to present at the Chardan's 10th Annual Healthcare Conference in New York. This event will take place on October 20, 2026, at The Lotte New York Palace.

The company's CEO, Marc Le Bozec, will engage in a fireside chat scheduled for 1.15pm ET (7.15pm CEST). During the conference, the management team will hold meetings with investors, aiming to discuss their innovative work in immuno-oncology and immuno-inflammation therapies.

OSE Immunotherapeutics is focused on developing first-in-class therapies to meet the needs of patients with serious conditions. The company collaborates with leading academic institutions and biopharmaceutical companies to bring transformative medicines to the market.